An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. (2015)
Attributed to:
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.coph.2015.07.005
PubMed Identifier: 26277332
Publication URI: http://europepmc.org/abstract/MED/26277332
Type: Journal Article/Review
Volume: 24
Parent Publication: Current opinion in pharmacology
ISSN: 1471-4892